Spiros Servos

Joined SiSaf 2019. Served at OXB, EBS, OGT and Ark. 25 years of industry experience. Completed more than thirty deals. Ph.D., MBA at Imperial College.

[Paras Sharma @paras_biotech]

World of ADC: PFE is ahead however NVS, Lilly, Gilead, JNJ and Amgen lagging behind.

Graph From Guggenheim

[SiSaf Ltd @SiSafLtd]

Our siRNA #therapeutic for Autosomal Dominant Osteopetrosis Type 2 (ADO2) has been granted both Rare Pediatric Disease Designation and Orphan Drug Designation by the #FDA, a major milestone to bring this revolutionary treatment to patients:https://t.co/uJbYynEExj

[SiSaf Ltd @SiSafLtd]

Our CEO @SiSafSuzanne & CFO are looking forward to attending #BioEquity next week in #Dublin, to talk about our #RNAdrugs pipeline and #BioCourier #RNA #delivery platform of silicon stabilised hybrid LNPs (#sshLNP).

#biotech #venturecapital #pharma #partnering #drugdelivery

[SiSaf Ltd @SiSafLtd]

Our batteries are recharged and we're preparing to fly to #SanFrancisco for @jpmorgan's Annual Healthcare Conference #JPM23 9-12 Jan.

Email [email protected] to meet our CEO or CFO to learn more about our safe, stable and efficient Bio-Courier #RNA #drugdelivery platform.

[Moderna @moderna_tx]

We announced today that we have received emergency use authorization (EUA) from the U.S. FDA for our BA.4/BA.5 Omicron-targeting #bivalent #COVID19 booster #vaccine, mRNA-1273.222, in children 6 months through 5 years of age.

Read more: https://t.co/yGBMzZpcXx

[Spiros Servos @sservos]

stable and efficient delivery of RNA.

Connect with us at [email protected] or visit our website https://t.co/plopnqc5O8 to see how we are advancing cutting-edge research into medical treatments.

#biotech #pharma #partnering #lifesciences #JPM23 #RNA #drugdelivery

[Spiros Servos @sservos]

Our CEO Dr Suzanne Saffie-Siebert and CFO Richard Scarrott will be in San Francisco from 9-12 January sharing updates on our development and opportunities to invest in and partner with our Bio-Courier platform of silicon stabilised hybrid lipid nanoparticles (sshLNP) for safe,

[Spiros Servos @sservos]

It is the most common chronic inflammatory and neurodegenerative disease of the central nervous system in young adults. It affects 100,000 people in the UK, and 2.3 million globally.
#stemcells #transplantation #AHSCT
https://t.co/d4Dp4S0Cya

[Spiros Servos @sservos]

New trial #StarMS will test if #stemcell #transplantation could be used as a first-line treatment for patients with 'highly active' and ‘aggressive’ forms of #multiplesclerosis (MS).

[Spiros Servos @sservos]

Experts will test how #AHSCT affects patients with highly ‘active’ MS failing drug treatment, or as a first-line treatment for patients with the ‘aggressive’ MS.
The findings could revolutionise care for thousands of people who have MS.

[BioDrugs Journal @BioDrugsJournal]

Therapeutic siRNA: State-of-the-Art and Future Perspectives by Maik Friedrich & Achim Aigner
Gene knockdown via RNA interference can be induced by small interfering RNAs and opens novel avenues towards innovative therapies in many diseases. #openaccess
https://t.co/hreCQCen6T

[Spiros Servos @sservos]

Early detection of #PancreaticCancer Hirotsu Bio Science developed a new test (N-Nose®) by tweaking the genetic code of the nematodes (C. elegans). Users send a urine sample to a lab. Test in US by 2023. #early-diagnostic testing

https://t.co/YOKiX33Hsu

[Science Magazine @ScienceMagazine]

Researchers have developed a #mRNA lipid nanoparticle vaccine that contains antigens from all 20 known subtypes of influenza A & B viruses—a strategy that may serve as the basis for universal flu vaccines.

📄: https://t.co/7GapDbBfxP
#SciencePerspective: https://t.co/fr5juxizRN

[Spiros Servos @sservos]

Our CEO, Dr Suzanne Saffie-Siebert explains the advantages of SiSaf technology @GENnews. #sshLNP #Bio-Courier #nonviraldelivery #drugdelivery #lipidnanoparticle #LNPs #mRNAdelivery #mRNAvaccines #mRNAstability #RNAtherapeutics
https://t.co/U4NMtUOiIV

[Financial Times @FT]

Nasa successfully launches delayed mission to Moon https://t.co/PLAEi3GDj8

[Endpoints News @endpts]

AstraZeneca and Merck executives are now raising concerns about how the IRA will impact cancer drug development moving forward.

https://t.co/CIIAg8TAwm

[Spiros Servos @sservos]

Congratulations to #UMSOM’s team. Found the problem and an inexpensive solution. #COVID19 #SARSCovV2 2DG.

[Inside Precision Medicine @Inside_PM]

Researchers have found how a specific protein in #SARSCoV2 damages heart tissue in lab models. The group then used the drug 2-deoxy-D-glucose (2DG) to reverse the protein’s toxic effects on the heart. Read more: https://t.co/fPRiiIh81T

[Spiros Servos @sservos]

Non coding RNAs regulate protein expression up or down. #MicroRNA #miRNA.

[Genetic Engineering & Biotechnology News @GENbio]

MicroRNA Modus Operandi Expands to Include Protein Upregulation. Learn more: https://t.co/OijkXo8VKV

[BioBoyScout @BioBoyScout]

Major Congratulations @ArrowheadPharma $ARWR for hitting a home run on 3 major world-changing #ASCVD targets at #AHA22: Olpasiran - Lp(a), APOC3, and ANGPTL3. #RNAi is now the hottest drug modality in town.
https://t.co/dTSSWuqYgb

[The Innovation | Medicine @Innov_Medicine]

A medical breakthrough by scientists @imperialcollege could save thousands of heart patient's lives. they have developed beating heart patches which could restore the muscle strength lost after a heart attack. @TheBHF